Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0D2LC
|
|||
Drug Name |
Pyrimidinyl compound 1
|
|||
Synonyms |
PMID26293650-Compound-36
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
DOMAINEX LIMITED PERRIOR, Trevor, Robert NEWTON, Gary, Karl STEWART, Mark, Richard AQIL, Rehan
|
|||
Structure |
Download2D MOL |
|||
Formula |
C22H20N6O
|
|||
Canonical SMILES |
C1CCN(C1)C2=C(C=C(C=C2)C3=NC(=NC=C3)NC4=CC=CC(=C4)C(=O)N)C#N
|
|||
InChI |
1S/C22H20N6O/c23-14-17-12-15(6-7-20(17)28-10-1-2-11-28)19-8-9-25-22(27-19)26-18-5-3-4-16(13-18)21(24)29/h3-9,12-13H,1-2,10-11H2,(H2,24,29)(H,25,26,27)
|
|||
InChIKey |
KPMCSBDURLKXIY-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | NF-kappa-B-activating kinase (TBK1) | Target Info | Inhibitor | [1] |
Target's Patent Info | NF-kappa-B-activating kinase (TBK1) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | TBK1 inhibitors: a review of patent literature (2011 - 2014).Expert Opin Ther Pat. 2015;25(12):1385-96. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.